Phase 1 study
Recruiting Phase 1
This trial at a glance
Where this trial is running
| Site | City | State or country | Status at this site |
|---|---|---|---|
| CMAX Clinical Research | Adelaide | SA | Recruiting |
voxsanity.com.au · trial sites from public registries · registry record synced 15 October 2026 · not medical advice
Who can join
The official eligibility criteria
Registry text, reproduced exactly. These are the words the trial's sponsor published on ClinicalTrials.gov. They have not been edited, shortened or rewritten, and they are written for researchers rather than for patients.
Key Inclusion Criteria:
1. Willing and able to give written informed consent for participation in the trial.
2. Healthy male or female participant aged 18 to 50 years.
3. BMI ≥ 18 and ≤ 32.0 kg/m2 at the time of the screening period.
4. Medically healthy without abnormal clinically significant medical/surgical history, physical findings, vital signs, ECG, and laboratory values at the time of the screening period, as judged by the Investigator.
5. Vaccinated against meningococcal disease (caused by Neisseria meningitidis) with a meningococcal ACWY conjugate vaccine and a serogroup B vaccine, or willing to be vaccinated against meningococcal disease, Streptococcus pneumoniae vaccine, Haemophilus influenzae type B vaccine during the screening period of the trial.
Key Exclusion Criteria:
1. History of any clinically significant disease or disorder which, in the opinion of the Investigator, may either put the participant at risk because of participation in the trial, or influence the results or the participant's ability to participate in the trial.
2. Known or suspected hereditary asymptomatic complement deficiency.
3. Any clinically significant illness, medical/surgical procedure, or trauma within four weeks of the first administration of IMP.
4. Malignancy within the past five years, with the exception of in situ removal of basal cell carcinoma.
5. Any planned major surgery within the duration of the trial.
6. Extensive tattoos covering all potential injection areas, extensive scarring, or other barriers to subcutaneous injection, as judged by the investigator.
7. Participants who are pregnant, currently breastfeeding, or intend to become pregnant during the course of the trial.
8. At community risk for contracting meningococcal/ pneumococcal/Hib disease, at the discretion of the Investigator. Including recent contact with meningococcal disease and/or recent travel to risk areas for meningococcal disease contagion.
Dates on the record
Results, publications and the official record
- No results are posted on the official record yet.
- No publications are listed on the official record yet.
- Official record and contacts on ClinicalTrials.gov – contact details for each site are kept there, and are not copied onto this page.
Sources and dates
- ClinicalTrials.gov – the record this page reformats
- ClinicalTrials.gov processing date: 13 October 2026.
- This page last checked by Voxsanity: 15 October 2026.
Voxsanity reformats data from public registries into this layout. It does not edit, interpret or add to what the registry published.
Not medical advice.
Individual trial records are refreshed on a rolling basis rather than all at once, so a record may be up to several weeks old. Each trial page and trial card shows the date its own record was last synced. Where a record has lagged, its status, sites and enrolment can differ from the current registry state in either direction, so check the registry link on the trial page before acting on them.
Letter for your doctor
A one-page summary of this trial to print or email to your GP. It carries the registry's own record of the trial and its eligibility criteria, and nothing Voxsanity has written about whether it suits you.